Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and Neck

NCT02429089 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped Decided by the investigator due to the difficulties to recruit

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: LEE011

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain